Form 4: Amneal Pharmaceuticals EVP, Chief Legal Officer Jason B. Daly Sells Shares

Jason B. Daly, EVP and Chief Legal Officer of Amneal Pharmaceuticals, sold a total of 90,000 shares of Class A Common Stock in two transactions on March 5th and 6th, 2025.

Summary

• On March 5, 2025, Jason B. Daly, the EVP and Chief Legal Officer of Amneal Pharmaceuticals, sold 43,064 shares of Class A Common Stock at a weighted average price of $8.88.
• The shares were sold in multiple transactions with prices ranging from $8.62 to $9.00 per share.
• Following this transaction, Daly beneficially owned 79,542 shares.
• On March 6, 2025, Daly sold an additional 46,936 shares of Class A Common Stock at a weighted average price of $8.73.
• These shares were sold in multiple transactions with prices ranging from $8.64 to $8.84 per share.
• After the second transaction, Daly's beneficial ownership decreased to 32,606 shares.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to periodically sell shares for personal financial management.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although it is a common practice.

Key Dates